{ }
Ethereum whale dominance has reached an all-time high, with 104 wallets holding over 100,000 ETH, representing 57.35% of the total supply. While whales accumulate more ETH, smaller investors are losing ground, controlling just 9.19% of the supply. This trend raises questions about potential market movements, as past whale accumulation has led to significant price changes, both bullish and bearish.
Ramzi Issa, a former UBS banker known for pioneering debt-for-nature swaps, has launched Enosis Capital, a Delaware-based credit fund, following his departure from UBS in October. The firm aims to focus on debt conversions and impact-focused transactions, leveraging Issa's expertise in the growing market for such deals. Recent participants in debt swaps include JPMorgan Chase, Bank of America, and Standard Chartered, with countries like El Salvador, Barbados, and Ecuador securing agreements.
Bank of America’s December Global Fund Manager Survey indicates a potential "sell" signal for risk assets, with cash levels at a three-year low and a significant bullish sentiment among investors. The average cash allocation among fund managers has fallen to 3.9%, triggering a contrarian indicator that historically suggests a market peak. Previous instances of similar cash levels have led to negative returns in global equities, while current allocations show a preference for US stocks and global banks, despite a notable underweight in European equities.
Chainlink (LINK) is experiencing a bullish surge, currently trading at $29 with an 8.35% weekly increase and a remarkable 104% rise over the past month. Institutional interest is growing, highlighted by Grayscale's Chainlink Trust and significant investments, boosting market credibility. Analysts predict LINK could reach $34 in the short term and $47 long-term, supported by strategic partnerships and increased whale activity, despite potential corrections.
Chainlink (LINK) has surpassed $29 for the first time in over three years, driven by significant accumulation from large holders, including whales and sharks. In the past two months, wallets with 100,000 or more LINK tokens have acquired 5.69 million LINK, while smaller wallets have sold nearly the same amount. This shift indicates a potential for continued growth, contingent on Bitcoin's stability and broader market conditions, highlighting the importance of strategic accumulation for long-term gains.
CRISPR Therapeutics AG (NASDAQ:CRSP) experienced a 6.4% decline in short interest in November, totaling 18,150,000 shares. Analysts have mixed ratings, with a consensus "Hold" and a target price of $77.93, while CEO Samarth Kulkarni sold 30,000 shares, reducing his stake by 13.24%. The company reported a quarterly EPS of ($1.01), surpassing estimates, but revenue fell short at $0.60 million.
Bitcoin and Ethereum led a remarkable $3.2 billion in weekly inflows into digital asset investment products, marking the 10th consecutive week of growth and pushing year-to-date inflows to a record $44.5 billion. Bitcoin attracted $2 billion, while Ethereum saw $1 billion, reflecting strong investor confidence and institutional adoption. Other altcoins like XRP, Polkadot, and Litecoin also experienced notable inflows, indicating a diversified interest in the crypto market.
Ethereum has surged past the critical resistance level of $3,953, with a target of $5,250 in sight, driven by increased whale activity and record inflows into Ethereum ETFs, totaling over $2 billion. The tightening supply and growing institutional interest suggest a bullish outlook, potentially leading to new all-time highs if momentum is sustained. Key factors include maintaining the price above $3,953 and the weekly RSI surpassing 70%.
JBWere has launched two new active fixed income products in partnership with UBS Asset Management, aimed at wholesale clients seeking defensive investment strategies. The UBS JBWere Australian Credit Fund and UBS JBWere International Credit Fund will provide access to expertly managed portfolios, responding to the growing demand for sophisticated fixed income solutions. These products will be available exclusively to JBWere clients by December 2025, reflecting a commitment to high-quality investment tailored to client needs.
JBWere has launched two new active fixed income products in partnership with UBS Asset Management, aimed at wholesale clients seeking defensive investment strategies. The UBS JBWere Australian Credit Fund and UBS JBWere International Credit Fund will provide access to expertly managed portfolios, responding to the growing demand for sophisticated fixed income solutions. These products will be available exclusively to JBWere clients by December 2025, reflecting a commitment to high-quality investment tailored to client needs.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.